Crossover in vivo study: investigation of the redox status of study participants before and after ingestion of vitamin C in blood. - Trial DRKS00028934
Access comprehensive clinical trial information for DRKS00028934 through Pure Global AI's free database. This phase not specified trial is sponsored by Charité-Universitätsmedizin Berlin, Dermatologie10117 BerlinGermany and is currently Recruitment Completed. The study focuses on None ;Healthy volunteers.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Deutsches Register Klinischer Studien data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Interventional
Sponsor & Location
Charité-Universitätsmedizin Berlin, Dermatologie10117 BerlinGermany
Timeline & Enrollment
N/A
N/A
N/A
Summary
The aim of the in vivo study is to show that an increase in the vitamin C dose in physiological concentrations leads to anti-oxidative protection, which can be demonstrated quantitatively/qualitatively in the blood. However, if the critical vitamin C concentration is exceeded, there may be an increase in radical production (pro-oxidative effect) or saturation or a shift in the proportion of radical species.
ICD-10 Classifications
Data Source
Deutsches Register Klinischer Studien
DRKS00028934
Non-Device Trial